Cipla USA, Inc. is recalling 59,244 packs of Ipratropium Bromide and Albuterol Sulfate Inhalation Solution USP (0.5 mg & 3mg/3mL). The recall was initiated because some vials (respules) were found to have less liquid than required, and drops of liquid were observed inside the intact sealed pouches. This prescription medication is used to treat respiratory conditions, and a short-filled vial may not provide the full prescribed dose.
A vial with less medication than intended could result in a patient receiving an insufficient dose to treat their respiratory symptoms. Additionally, liquid leaking into the pouch indicates the container may not be properly sealed, which could affect the sterility or stability of the medication.
You have 2 options:
Manufactured for Cipla USA, Inc. by Cipla Ltd., Indore SEZ, Pithampur, India.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.